DOXORUBICIN HYDROCHLORIDE
NDC 70748-339, DOXORUBICIN HYDROCHLORIDE, injection, suspension, liposomal, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 70748-339
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215178
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70748-339 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXORUBICIN HYDROCHLORIDE2 mg/mL
Pharmacologic classes
Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70748-339-01 | 70748033901 | 1 VIAL, SINGLE-USE in 1 CARTON (70748-339-01) / 10 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0f8eb9a1-74d0-47fd-94b8-a65b29006521Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70748-339
Use it
Look up 70748-339 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70748-339 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70748-339. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.